Penn spinout Carisma Therapeutics reducing workforce by 37%

The company posted a net loss $86.9 million in 2023 and joins a growing list of life sciences companies trimming their workforces.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news